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Abstract Bacillus megaterium P450 BM3 is a fatty acid
hydroxylase with selectivity for long chain substrates (C12^
C20). Binding or activity with substrates of chain length 6C12
has not been reported. Rational mutagenesis was used to re-
design the enzyme to encourage binding of short chain fatty acids
(C4^C10). We show that wild-type P450 BM3 has activity and
weak affinity for substrates as short as butyrate (C4). However,
turnover/binding of short chain substrates is dramatically
increased by introducing a novel substrate carboxylate binding
site close to the heme. Mutant L181K shows catalytic efficiency
(kcat/KM) increased s 13-fold with butyrate, while the L75T/
L181K double mutant has kcat/KM increased s 15-fold with
hexanoate and binding (Kd) improved s 28-fold for butyrate.
Removing the arginine 47/lysine 51 carboxylate binding motif at
the mouth of the active site disfavours binding of all fatty acids,
indicating its importance in the initial recognition of
substrates. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Cytochromes P450 (P450s) are cysteine-ligated haem-con-
taining monooxygenases widespread in nature [1]. They have
important metabolic functions (including steroid syntheses
and transformations), play roles in detoxi¢cation of drugs
and xenobiotics, and catalyse breakdown of unusual com-
pounds as carbon sources for growth [2,3]. Their predominant
reaction is the mono-oxygenation of organic molecules by the
activation and insertion of an atom from molecular O2
(Scheme 1). However, other reactions (e.g. dealkylation)
have also been reported [4].
RHO2  2H  2e3 ! ROHH2O Scheme 1
Analysis of soluble bacterial P450s such as the camphor
hydroxylase from Pseudomonas putida and the fatty acid hy-
droxylase from Bacillus megaterium have given insights into
the structure and function of their membrane-bound eukary-
otic counterparts [5]. The X-ray crystal structures of bacterial
P450s have allowed various aspects, key to their function, to
be investigated by a rational approach. Bacterial structures
also have important biotechnological roles as models for the
eukaryotic P450s for e.g. design of new drugs, and have great
potential to catalyse novel reactions inaccessible to conven-
tional chemistry.
One of the most intensively studied of the bacterial P450s is
the £avocytochrome P450 BM3, a high activity fatty acid
hydroxylase from B. megaterium [6]. P450 BM3 is a natural
fusion of a P450 to a mammalian-like di£avin NADPH-P450
reductase and is of great importance in understanding struc-
ture, function and electron transfer in this enzyme class.
In this study, we have altered substrate selectivity in P450
BM3. The substrate (palmitoleate)-bound P450 BM3 structure
reveals several hydrophobic residues within van der Waals
contact of the substrate [7]. Using rational site-directed muta-
genesis, we have replaced selected neutral residues with pos-
itively charged or more hydrophilic residues in attempts to
pinpoint substrate binding determinants. We have also at-
tempted to copy the fatty acid carboxylate binding motif
(R47/Y51, found at the mouth of the active site) at positions
further down the substrate binding channel to encourage
binding of shorter chain fatty acids. To date, no research
has successfully addressed reasons for the observed substrate
selectivity pro¢le of this important £avocytochrome, which
only has reported activity for fatty acids of chain length
C12^C20. Here we provide evidence that rational mutagenesis
can be used to convert P450 BM3 to favour binding of shorter
chain (C4^C10) fatty acids.
2. Materials and methods
All P450 BM3 substrates (arachidonic acid and sodium laurate
(C12), decanoate (C10), octanoate (C8), hexanoate (C6) and butyrate
(C4)) were from Sigma (St. Louis, MO, USA). Oligonucleotide prim-
ers were from PE Biosystems. Restriction and DNA modi¢cation
enzymes were from New England Biolabs. All other reagents were
from Sigma. The arachidonic acid stock solution was 33 mM (approx-
imately 10 mg ml31) in ethanol. All other substrates were prepared as
aqueous solutions in the assay bu¡er for P450 BM3 reactions (20 mM
MOPS, pH 7.4, plus 100 mM KCl). NADPH was prepared as a 20
mM stock in ice-cold degassed assay bu¡er.
Cloning of P450 BM3 and generation of mutants R47A and Y51F
has been described previously [8,9]. Site-directed mutagenesis of £a-
vocytochrome P450 BM3 and its haem (P450) domain was according
to Kunkel [10,11]. Oligonucleotides used to construct the indicated
mutants were as follows (plasmid nomenclature in parentheses, under-
lined bases indicate mismatches): L181K (pCM21) ^ 5P-CATTGCTT-
CATCCTTTGCACGGACCATAC-3P L181R (pCM22) ^ 5P-GCTT-
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CATCCCGTGCACGGAC-3P L437K (pCM23) ^ 5P-GGTTTTAAC-
GTTTTAGTTTAATATCC-3P L437R (pCM24) ^ 5P-GGTTTTAAC-
GTTCGAGTTTCTTTAATATCC-3P I263K (pCM61) ^ 5P-GTTTC-
GTGTCCCGCTTTTAAGAATGTAAT-3P L75K (pCM59) ^ 5P-CG-
TACAAATTTCTTCGCTTGACTTAAG-3P L181K/L75T (pCM60) ^
5P-CGTACAAATTTAGTCGCTTGACTTAAG-3P
Double mutant R47A/Y51F was prepared by mutagenesis of exist-
ing clone pCM25 (R47A) [9] using primer 5P-GACTTGATAA-
GAAGCGCGTTAC-3P. Triple mutant R47A/Y51F/L181K was gen-
erated by digestion of the existing plasmid clones pCM28 (R47A/
Y51F) and pCM21 (L181K) with SpeI and A£II, followed by puri¢-
cation of the smaller (1.5 kb) fragment from the pCM28 digest and
the larger (V6.5 kb) fragment from the pCM21 digest by elution after
agarose gel electrophoresis. These fragments were re-ligated to gener-
ate clone pCM29 (R47A/Y51F/L181K). All mutations were veri¢ed
by sequencing the complete gene. Plasmid preparations, transforma-
tions and dideoxy DNA sequencing (to verify mutations) were per-
formed by standard methods [12]. Escherichia coli strain TG1 was
used for the expression of the enzymes [13].
Wild-type and mutant P450s BM3 were expressed under the control
of the BM3 promoter system, which is highly active in stationary
phase. Transformed E. coli cells were grown in Luria^Bertani medium
supplemented with 25 Wg ml31 carbenicillin. Enzymes were puri¢ed
following the reported protocol [8]. Pure proteins were concentrated
to V200 WM by ultra¢ltration, dialysed against 1 l of storage bu¡er
(50 mM Tris^HCl, 1 mM EDTA, pH 7.4) containing 50% (v/v) glyc-
erol, and stored frozen at 380‡C.
Steady-state kinetic assays were performed at 30‡C in assay bu¡er.
Substrate oxidation assays were performed as described previously [9],
monitoring coupled oxidation of NADPH at 340 nm (O340 = 6210 M31
cm31). Enzyme concentration was 93 WM and substrate (carboxylic
acids of di¡ering chain length from butyric acid (C4) up to arachi-
donic acid (C20)) was added over a range of di¡erent concentrations,
according to the enzyme a⁄nity. The reaction was initiated by addi-
tion of NADPH (200 WM). Initial rate of substrate oxidation was
measured over the ¢rst minute. Speci¢c enzyme rates were calculated
and plotted against substrate concentration, and the data ¢tted to the
Michaelis function to generate kcat and KM parameters.
Substrate dissociation constants (Kd values) were determined by
following the low- to high-spin perturbations of the ferric absorption
spectra (absorbance shift from 419 to 390 nm) upon substrate-induced
removal of the sixth (water) ligand to the heme iron. Titrations were
performed either by addition of small (6 0.5 Wl) volumes of alcoholic
arachidonic acid using a Hamilton syringe (6 5 Wl total), or by mixing
aliquots of substrate-free enzyme solution with substrate-saturated
aqueous solutions containing enzyme at the identical concentration.
By mixing substrate-free and substrate-saturated enzyme solutions in
di¡erent ratios, the desired substrate concentration is obtained. Spec-
tra were recorded between 800 and 300 nm at each point in the titra-
tion. Di¡erence spectra were generated and the maximum absorbance
di¡erence calculated. Di¡erences were plotted against substrate con-
centration and ¢tted to a rectangular hyperbola to generate the Kd in
each case. All data manipulations and non-linear least-squares curve-
¢tting were performed using Origin (Microcal).
Determinations of P450 integrity and concentration were achieved
by generating the ferrous-CO adduct of each enzyme. Reduction was
performed by addition of sodium dithionite to the enzyme (V5 WM)
in assay bu¡er, and carbon monoxide gas was bubbled into the solu-
tion slowly for 60 s to generate the characteristic P450 complex. In all
cases, there was near complete (s 95%) conversion to the ferrous-CO
adduct at 450 nm (‘P450’), indicative of active protein. Negligible
amounts of the inactive (‘P420’) species were observed. P450 concen-
tration was determined from the reduced/CO-bound minus reduced
di¡erence spectrum, using O450ÿ490 = 91 mM31 cm31.
3. Results and discussion
Our mutagenesis strategy was based on examination of the
active site of palmitoleate-bound P450. Residues in the central
region of the long, hydrophobic channel in van der Waals
contact with the substrate and less than 10 Aî from the
heme were selected as mutagenesis targets (Fig. 1). Since the
Arg47, Tyr51 motif at the active site mouth is essential both
for binding carboxylate groups of long chain substrates and
transition state stabilisation [7,9], we constructed a series of
mutants in which the selected hydrophobic amino acids
(Leu75, Leu181, Ile263 and Leu437) were altered. These
were changed to residues capable of forming hydrogen bonds
or salt bridges to the carboxylate group of shorter substrates
(C4^C10). We also examined the e¡ects of removing the R47/
Y51 motif, to assess whether short-chain fatty acids were then
Fig. 1. Important amino acids in the X-ray atomic structure of palmitoleate-bound P450 BM3. Several amino acids have key roles in substrate
association (R47, Y51, F42 [9]), regioselectivity of substrate oxidation (F87 [21]), haem incorporation and haem iron spin-state regulation (W96
[22]) and coordination of the haem iron (C400). Other residues within the substrate binding pocket are in van der Waals contact with substrate,
and were targets for mutagenesis in this study.
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capable of di¡using further into the active site without becom-
ing tethered in a position unfavourable for catalysis.
All mutant enzymes had a full complement of £avin and
heme, indicating the mutations did not cause major disruption
to the tertiary structure. Catalytic (kcat and KM) and substrate
binding (Kd) studies of wild-type P450 BM3 showed there was
modest binding (KM, Kd in mM range) of substrates with
chain length shorter than laurate (Tables 1 and 2). However,
mutants L181R, L437K, L437R and R47A/Y51F/L181K
showed weaker binding and lower catalytic activity than
wild-type P450 BM3 with all substrates. The L437K and
L437R mutant enzymes were particularly severely a¡ected.
L437R had rates of 6 10 min31 with all substrates, and max-
imal activity obtained with L437K was only 120 þ 4 min31
with arachidonate, almost 150-fold lower than wild-type
P450 BM3.
Mutants I263K and L75K retained considerable activity
(kcat, min31) with laurate (1014 þ 14 and 1090 þ 34, respec-
tively cf 5140 þ 90 for wild-type P450 BM3) and arachidonate
(1443 þ 73 and 1395 þ 54 cf 17100 þ 190 for wild-type P450
BM3), but showed no activity improvement (kcat) with short
chain substrates. However, KM values (mM) for I263K and
L75K were lower for hexanoate (49 þ 7.6 and 114 þ 18, respec-
tively, cf 243 þ 49 for wild-type), octanoate (14.6 þ 1.1 and
9.8 þ 1.3 cf 39 þ 9.0) and decanoate (0.85 þ 0.06 and 2.5 þ 0.3
cf 6 þ 1). These KM improvements lead to small increases in
e⁄ciency (kcat/KM) over wild-type for I263K with hexanoate
(4.3-fold) and octanoate (1.9-fold), and for L75K with octa-
noate (2.7-fold). Spectral measurements also indicated im-
provements in hexanoate and decanoate binding for L75K
(Kd values = 79 þ 19 mM and 0.63 þ 0.09 mM, respectively).
A feature of mutant I263K was that, for all substrates, spin-
state perturbation on substrate binding was much less than
for wild-type P450 BM3. This prevented accurate determina-
tion of Kd values for substrates other than laurate and ara-
chidonate. Mutants I263K and L75K showed encouraging
changes in substrate chain length speci¢city. However three
other mutants (R47A/Y51F, L181K and L75T/L181K)
showed more dramatic alterations in activity and selectivity,
and are discussed in more detail below.
3.1. R47A/Y51F
In P450 BM3, both the arginine 47-to-carboxylate salt
bridge and the tyrosine 51-to-carboxylate hydrogen bond
are important for e⁄cient catalysis [7]. The contribution of
R47 is more important to fatty acid binding [9]. By creating
the double mutant enzyme R47A/Y51F we sought to inves-
tigate two distinct problems: (1) whether total removal of this
motif has severe e¡ects on binding of long chain substrates,
and (2) whether binding and catalysis of shorter chain sub-
strates is favoured due to their ability to di¡use further into
the active site, following removal of a motif that would oth-
erwise ‘trap’ them distant from the heme iron. Signi¢cant
decreases in kcat and increases in KM for both laurate and
arachidonate were measured for R47A/Y51F (Table 1). These
resulted in 4.3- and 37.1-fold decreases in e⁄ciency (kcat/KM)
for laurate and arachidonate, respectively, compared to wild-
type. The cumulative e¡ect of the two mutations is greater
than the e¡ect of either in isolation [9]. Thus, both residues
are needed for e⁄cient function of P450 BM3, supporting
recent predictions [14].
Characterisation of the properties of the R47A/Y51F en-
zyme with fatty acids shorter than C12 chain length showed
that there was no improvement in binding (Table 2) and that
Table 1
Catalytic parameters for wild-type and mutant P450s BM3
Enzyme Substrate
C4 C6 C8 C10 C12 C20
Wild-type kcat (min31) 88 þ 6 229 þ 26 1364 þ 153 6393 þ 486 5140 þ 90 17100 þ 190
KM 387 þ 66 mM 243 þ 49 mM 39 þ 9 mM 6 þ 1 mM 290 þ 20 WM 4.7 þ 0.3 WM
kcat/KM (mM min31) 0.23 þ 0.065 0.94 þ 0.35 35 þ 15.5 1066 þ 310 17700 þ 1700 (3.64 þ 0.29)U106
R47A/Y51F kcat (min31) 142 þ 16 156 þ 31 692 þ 61 1654 þ 88 2095 þ 88 3234 þ 199
KM 463 þ 123 mM 480 þ 134 mM 46 þ 10 mM 4.6 þ 0.6 mM 514 þ 48 WM 33 þ 4 WM
kcat/KM (mM min31) 0.307 þ 0.154 0.325 þ 0.215 15.0 þ 5.9 360 þ 75 4080 þ 600 98000 þ 20400
L181K kcat (min31) 353 þ 7 166 þ 10 747 þ 20 547 þ 35 693 þ 27 3073 þ 174
KM 116 þ 8 mM 121 þ 14 mM 4.0 þ 0.3 mM 3.8 þ 0.6 mM 134 þ 20 WM 6.3 þ 0.7 WM
kcat/KM (mM min31) 3.04 þ 0.29 1.37 þ 0.27 187 þ 20 144 þ 38 51700 þ 11500 (4.88 þ 0.92)U105
L181K/L75T kcat (min31) 205 þ 17 2590 þ 212 3256 þ 128 116 þ 7 269 þ 13 14006 þ 624
KM 602 þ 79.5 mM 177 þ 32.5 mM 19.7 þ 2.1 mM 2.67 þ 0.36 mM 316 þ 38 WM 9.3 þ 1.4 WM
kcat/KM (mM min31) 0.34 þ 0.08 14.6 þ 4.8 165 þ 27 43 þ 10 850 þ 160 (1.51 þ 0.35)U106
The kcat and KM values were determined as described in Section 2. Catalytic e⁄ciency of wild-type and mutant P450s was calculated as the
kcat/KM ratio. ND = ‘not determinable’, and indicates that catalytic rate was not signi¢cantly higher than background, preventing accurate deter-
mination of the kcat and KM values.
Table 2
Binding (dissociation) constants for wild-type and mutant P450s BM3
Enzyme Substrate and Kd (mM)
C4 C6 C8 C10 C12 C20
Wild-type 261 þ 27 131 þ 10 12 þ 2 2.6 þ 0.4 (241 þ 7)U1033 (3.6 þ 0.3)U1033
R47A/Y51F ND ND 50 þ 14 ND ND (5.3 þ 0.2)U1033
L181K 91 þ 18 246 þ 32 4 þ 1 (312 þ 26)U1033 (255 þ 33)U1033 (2 þ 0.2)U1033
L181K/L75T 9.3 þ 1.9 18.5 þ 5.4 5.1 þ 0.9 0.99 þ 0.12 (297 þ 30)U1033 (14 þ 1.5)U1033
Kd values were determined by spectral titration as described in Section 2. ND = ‘not determinable’, and indicates that extent of spectral shift in-
duced by the substrate was not great enough to enable the accurate determination of a Kd value.
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catalytic e⁄ciency was reduced s 2-fold for C6 to C10 sub-
strates. For butyrate, there was no signi¢cant di¡erence in
catalytic e⁄ciency between R47A/Y51F and wild-type (Table
1). Clearly, removal of the motif does not improve the short
chain selectivity by preventing molecules from binding at the
mouth of the active site. In fact, it appears to be important for
the binding of substrates of all chain length, probably by the
recognition of substrates from the bulk solution (Fig. 2).
A hydrophobic patch at the surface of the haem domain,
adjacent to the active site, is postulated to act as an initial
surface for substrate interaction [7]. The palmitic acid binding
properties of a P25Q mutant in this region (Kd increased
V100-fold) are consistent with this postulate [15]. However,
substrate cannot enter directly into the long hydrophobic ac-
tive site channel, since mutual hydrophobic e¡ects cannot be
transmitted long-range in solution. Instead, we consider that
the fatty acid carboxylate is attracted by electrostatic (solu-
tion-transmissible) forces to the guanidinium group of R47 at
the mouth of the active site. Once this occurs, a hydrogen
bond to the hydroxyl group of Y51 can also form. At this
point, there is a strong driving force for the movement of the
long hydrophobic tail of the fatty acid from the polar solvent
phase into the substrate binding channel. Once inside, inter-
actions with several hydrophobic side-chains occur. Thus, the
R47/Y51 motif is critical for guidance of fatty acids into the
active site.
3.2. L181K
This was the most successful single mutant studied. L181K
has decreased catalytic e⁄ciency with long chain substrates,
but markedly improved e⁄ciency with shorter chain fatty
acids, particularly butyrate (13-fold over wild-type) and octa-
noate (5-fold) (Table 1). Catalytic e⁄ciency is not signi¢cantly
di¡erent from wild-type for hexanoate, and is decreased 7-fold
for decanoate. However, in both cases it is kcat that is unfav-
ourably a¡ected. The KM for hexanoate and decanoate is
actually decreased compared to wild-type (Table 1). The
L181K Kd is also decreased for butyrate, octanoate and dec-
anoate. Mutant L181K shows large conversion in substrate
selectivity, with the ratio of catalytic e⁄ciency (kcat/KM) for
short chain fatty acids to that for arachidonate increased 99-
fold for butyrate and 40-fold for octanoate over wild-type.
Interestingly, L181R does not show similar characteristics
and is severely a¡ected in catalysis. The kcat values for this
mutant are 6 40 min31 for all substrates 9C10, and only
584 þ 14 min31 for arachidonate. Substrates of chain length
6C12 do not induce a signi¢cant spin-state shift in the L181R
heme, preventing determination of Kd. Clearly, length and/or
mobility of the lysine sidechain are critical factor(s) in pro-
moting the observed substrate selectivity changes in L181K.
Also notable is that triple mutant R47A/Y51F/L181K is se-
verely impaired in binding and catalysis with all substrates.
There is no measurable activity with substrates of chain
length 6C10, and activity is only 1213 þ 38 min31 with ara-
chidonate. Clearly the L181K mutation cannot compensate
for the absence of the R47/Y51 substrate binding motif.
3.3. L75T/L181K
In this double mutant, we combined the best single muta-
tion (L181K) with a second mutation in which L75 was mu-
tated to an amino acid (threonine) with a hydroxyl containing
side-chain. Here, we attempted to recreate, close to the heme,
a motif (lysine/threonine) with similar chemical character and
bonding capability to the R47/Y51 motif at the active site
mouth. The L75T/L181K double mutant also showed marked
alterations in substrate selectivity (Tables 1 and 2). The most
striking improvements in catalytic properties of L75T/L181K
are the large increases in kcat with hexanoate and octanoate.
KM values for these substrates are also lower than for wild-
type, leading to 15.5-fold (hexanoate) and 4.7-fold (octanoate)
increases in catalytic e⁄ciency. Kd measurements also indicate
considerable improvements in binding of butyrate and hexa-
noate, with the Kd for octanoate essentially unaltered from
that for L181K. Catalytic e⁄ciency with butyrate is also un-
altered compared to L181K. The L75T/L181K double mutant
has a binding and catalytic pro¢le distinct from the L181K
single mutant, with improved catalytic parameters for hexa-
noate.
Fig. 2. Model for substrate interaction in P450 BM3. A hydropho-
bic patch adjacent to the active site entrance makes initial interac-
tions with the alkyl chain of fatty acids. (A) Electrostatic forces ori-
entate the substrate carboxylate group towards R47, and a
hydrogen bond between the carboxylate and the hydroxyl group of
Y51 further stabilises the binding. (B) The alkyl chain of the sub-
strate is drawn into the active site channel, where favourable hydro-
phobic interactions ensure strong association. (C) The ¢nal catalyti-
cally competent orientation is achieved, in readiness for haem
reduction and the initiation of the catalytic cycle.
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Few amino acids are well conserved throughout the P450s,
exceptions being those in the heme binding motif around the
absolutely conserved cysteine that provides the sulfhydryl li-
gand to the heme iron (C400 in P450 BM3) [16]. However, the
leucine corresponding to L181 in P450 BM3 is conserved in
several P450s, particularly in members of the CYP 4 family ^
fatty acid hydroxylases. In many P450s, a hydrophobic resi-
due is conserved at this position, usually a phenylalanine in
P450s exhibiting speci¢city for aromatic substrates [17]. One
of the most interesting of all P450 protein engineering results
was obtained by mutation at the position corresponding to
L181 in mouse P450s 2A4 and 2A5. These two enzymes di¡er
by only 11 amino acids, but have marked di¡erences in sub-
strate speci¢city. P450 2A4 catalyses 15K-hydroxylation of
testosterone and has a leucine at position 209 (corresponding
to L181 in P450 BM3). P450 2A5 catalyses coumarin 7-hy-
droxylation and possesses a phenylalanine here. Swapping
these residues reverses substrate speci¢city, such that P450
2A4 L209F catalyses coumarin hydroxylation and vice versa
for testosterone [18]. Thus it is possible that L181 of P450
BM3 is located at a position of importance in dictating
P450 substrate selectivity. Leucine 181 is located in the centre
of the F-helix, a motif postulated to be involved in substrate
interactions as part of SRS2 (substrate recognition sequence
2) in Gotoh’s model [19]. The leucine is also conserved as the
¢nal residue of the steroid recognition ‘GERL’ motif in P450s
of subfamilies 11A and 11B [20].
4. Conclusions
In this study, we have demonstrated for the ¢rst time that
P450 BM3 has measurable a⁄nity for alkanoic acids shorter
than C12, and also that preference for fatty acids of this chain
length can be selectively enhanced by rational mutagenesis.
The single mutation L181K reduced the Kd for decanoate to
micromolar levels (312 þ 26 WM), and induced large increases
in catalytic e⁄ciency and a⁄nity (Kd) for butyrate and octa-
noate. By introducing a second mutation (L75T), some fur-
ther improvements were obtained. In particular, mutant
L75T/L181K showed a huge kinetic improvement with hexa-
noate. Mutants L181K and L75T/L181K are considerably im-
proved enzymes for the binding and catalysis of short-chain
fatty acids, providing evidence for a key role for L181 in
controlling P450 BM3 substrate selectivity.
Removal of the carboxylate binding R47/Y51 motif dimin-
ishes catalytic capacity with all substrate chain lengths, indi-
cating its importance in preliminary substrate binding inter-
actions (Fig. 2). Clearly, this motif should not be altered in
future attempts to re-engineer P450 BM3 fatty acid chain
length selectivity.
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